EBV Early Antigen Ab
EBV Early Antigen Ab is a clinical biomarker on the Infection panel, reported in U/mL. Standard reference range: 0–8.9 U/mL. Functional (optimal) range used by integrative practitioners: 0–6.5 U/mL.
What is EBV Early Antigen Ab?
EBV early antigen (EA) antibodies are associated with active viral replication; they can persist in chronic active EBV infection and may be elevated in some lymphomas.
Reference ranges
| Range type | Value (U/mL) | Source |
|---|---|---|
| Standard (lab) | 0–8.9 | Typical Quest / LabCorp adult reference |
| Functional (optimal) | 0–6.5 | Integrative / functional medicine consensus |
How SomaVue interprets EBV Early Antigen Ab
SomaVue maps every result for EBV Early Antigen Ab against four clinical lenses — nutrient cofactors, toxin exposure, infection drivers, and circadian/hormonal context — and connects each interpretation to specific peer-reviewed citations. Pre-mapped clinical reasoning and cross-marker pattern detection are available inside the practitioner workspace.
See the full interpretation
Upload a patient PDF or enter values manually to see the four-lens analysis, cross-marker patterns, and cited evidence for EBV Early Antigen Ab and 205 other markers.
Try it freeEducational reference only. Reference ranges vary by laboratory, assay method, age, sex, and clinical context. Functional ranges represent integrative-medicine consensus and are not regulatory thresholds. SomaVue does not diagnose, treat, mitigate, or prevent disease. Always consult a licensed healthcare provider.